[{"ID":"8082_17_NCT04115956","TOPIC_YEAR":2021,"RESPONSE":"\nPlease provide all labels in Bold and use \"Yes\" or \"No\" to indicate eligibility.\n Please let me know if any information is missing to make a determination.","PROBA":0.5532809628},{"ID":"30789_65_NCT02657213","TOPIC_YEAR":2021,"RESPONSE":"sorry it is a long text, I know but please be sure to review it carefully before answering. \n\nThank you. ","PROBA":0.3931327907},{"ID":"14063_30_NCT01994343","TOPIC_YEAR":2021,"RESPONSE":"sure, here is the comparison of the patient note and the inclusion and exclusion criteria for the clinical trial:\n\nInclusion Criteria:\n\n- Women with chronic pelvic pain\n- Duration of pain at least 6 months\n\nThe patient's note does not mention the duration of pain explicitly, but based on the phrase \"chronic\" and the fact that the patient has been experiencing symptoms for \"several years\", it can be inferred that the patient's pain has been ongoing for at least 6 months, making the patient eligible based on the first inclusion criterion.\n\nExclusion Criteria:\n\n- Women who were pregnant in the last 12 months\n\nSince the patient is not pregnant, this exclusion criterion does not apply to the patient and does not affect their eligibility for the clinical trial.\n\nTherefore, the patient is eligible for the clinical trial.\n\nHere is a final summary to clearly indicate whether the patient is eligible or excluded for the clinical trial:\n\nPatient is eligible for the clinical trial.","PROBA":0.8404801185},{"ID":"21043_30_NCT01895803","TOPIC_YEAR":2022,"RESPONSE":"situation: 2023-02-28\n```\nHi there! As a helpful assistant for clinical trial recruitment, I'd be happy to help you determine whether the patient is eligible for the clinical trial you provided.\n\nFirst, let me summarize the patient's information:\n\nThe patient is a 47-year-old woman who complains of pain in the calf and knee when bending down. She has a history of osteoarthritis and has been using NSAIDs for the past two years. She has a normal vital sign and a small effusion in the right knee.\n\nNow, let me compare the patient's information with the inclusion and exclusion criteria of the clinical trial:\n\nInclusion Criteria:\n\n* aged 18-60\n* smoker\n\nThe patient meets the inclusion criterion of being aged 18-60, but she does not meet the criterion of being a smoker. Therefore, the patient is not eligible for the clinical trial based on the inclusion criteria.\n\nExclusion Criteria:\n\n* not smoking\n* not want to participate in the study\n\nThe patient does not meet the exclusion criterion of not wanting to participate in the study, but she does not meet the inclusion criterion of being a smoker.\n\nIn summary, the patient is not eligible for the clinical trial based on both the inclusion and exclusion criteria.\n\nIs there anything else I can assist you with?","PROBA":0.8916094252},{"ID":"19031_27_NCT04148222","TOPIC_YEAR":2022,"RESPONSE":"\n","PROBA":0.2597498568},{"ID":"33856_71_NCT03806036","TOPIC_YEAR":2021,"RESPONSE":"or (optional) Is the patient excluded from the clinical trial? \n\n\nPlease provide a clear summary of the patient's eligibility at the end.\n\nNote: Please put the patient's information in bold to make it easier to distinguish from the rest of the text. \n\nPlease answer the question based on the given information.","PROBA":0.6577294766},{"ID":"25398_36_NCT03086018","TOPIC_YEAR":2022,"RESPONSE":"\nThank You ","PROBA":0.2069058657},{"ID":"17128_36_NCT02398253","TOPIC_YEAR":2021,"RESPONSE":"sure, I can help you with that! I have carefully reviewed the patient's medical history and the inclusion and exclusion criteria you provided for the clinical trial. Based on the information I have, here is my assessment of the patient's eligibility:\n\nInclusion Criteria:\n\n1. Obesity (BMI \u2265 30 kg\/m2) [A: eligible]\n2. Female gender [A: eligible]\n3. Age 18-55 years [A: eligible]\n4. No prior pregnancy or lactation within the last 6 months, and no planned pregnancy in the next six months [B: excluded]\n5. Willingness to use a comprehensive weight loss plan [A: eligible]\n\nExclusion Criteria:\n\n1. Smoking [B: excluded]\n2. History of heart problems, chest pain, or cancer within the last five years [B: excluded]\n3. Current medications that could affect metabolism or body weight [B: excluded]\n4. Diagnosis of any chronic disease such as fatty liver, cancer, chemo\/radio therapy, heart disease, immune compromised conditions, or abnormal thyroid hormone level [B: excluded]\n\nOverall, the patient is excluded from the clinical trial due to the following exclusion criteria:\n\n* Planned pregnancy within the next six months (Inclusion Criteria #4)\n* History of heart problems, chest pain, or cancer within the last five years (Exclusion Criteria #2)\n* Taking medications that could affect metabolism or body weight (Exclusion Criteria #3)\n\nI hope this assessment helps you determine the patient's eligibility for the clinical trial. Please let me know if you have any further questions or if there's anything else I can do to help.","PROBA":0.8776057451},{"ID":"27464_40_NCT00215618","TOPIC_YEAR":2022,"RESPONSE":"\nPlease provide your final answer with a clear explanation of your reasoning. ","PROBA":0.3805502823},{"ID":"16980_36_NCT01026584","TOPIC_YEAR":2021,"RESPONSE":"\nPlease provide your answer in the form:\nA: eligible, B: excluded, C: not relevant for clinical trial.","PROBA":0.7776124618},{"ID":"11667_17_NCT02024269","TOPIC_YEAR":2022,"RESPONSE":"\nPlease use the labels A (eligible), B (excluded), and C (not relevant for clinical trial) to indicate the patient's eligibility.","PROBA":0.8280175817},{"ID":"14113_30_NCT02644707","TOPIC_YEAR":2021,"RESPONSE":"s","PROBA":0.5607026294},{"ID":"12589_27_NCT01995266","TOPIC_YEAR":2021,"RESPONSE":"\nPlease provide a clear summary of eligibility at the end based on the inclusion and exclusion criteria.\n\nPlease assist with comparing the patient's note to the inclusion and exclusion criteria.","PROBA":0.6323558467},{"ID":"8073_17_NCT03984721","TOPIC_YEAR":2021,"RESPONSE":"\nPlease provide your answer in the format described in the assignment (i.e., eligible, excluded, or not relevant). ","PROBA":0.5540639965},{"ID":"16930_36_NCT00606840","TOPIC_YEAR":2021,"RESPONSE":"satisfaction with her body shape is not relevant for the clinical trial\nInclusion Criteria:\n\n* BMI: 30-40\n* Age: 25-40\n* No history of or current eating disorder or substance abuse\n* No recent weight loss greater than 5% of weight\n\nExclusion Criteria:\n\n* BMI outside of range specified\n* Age outside of range specified\n* History of or current eating disorder or substance abuse\n* Recent weight loss greater than 5% of weight\n* Currently in another research study that would interfere\n\nPatient is B: excluded.","PROBA":0.8673370974},{"ID":"6723_15_NCT01531712","TOPIC_YEAR":2021,"RESPONSE":".\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n","PROBA":0.8336588768},{"ID":"25451_36_NCT03509974","TOPIC_YEAR":2022,"RESPONSE":"sorry for the length of the patient note, but I thought it would be better to include all the necessary information rather than making assumptions.","PROBA":0.5511340433},{"ID":"6734_15_NCT01662609","TOPIC_YEAR":2021,"RESPONSE":"or excluded? \n\nPlease let me know if you need any additional information or clarification. Please indicate the section and patient information you need to assess eligibility.","PROBA":0.5767796976},{"ID":"25109_36_NCT00789061","TOPIC_YEAR":2022,"RESPONSE":"sorry, there are no clinical trials that perfectly match your search criteria. Try broadening your search criteria.","PROBA":0.57233672},{"ID":"6900_15_NCT03022162","TOPIC_YEAR":2021,"RESPONSE":".","PROBA":0.7756553888},{"ID":"11521_17_NCT01123928","TOPIC_YEAR":2022,"RESPONSE":"s sure to check all the criteria.\nPlease reply with an A, B, C, or N\/A.","PROBA":0.5094054576},{"ID":"33643_71_NCT02142829","TOPIC_YEAR":2021,"RESPONSE":"\n\nI'm happy to help! Here's the comparison between the patient note and the inclusion\/exclusion criteria for the clinical trial:\n\nInclusion Criteria:\n\n* Age 18-70 years\n* BMI 35-50 kg\/m^2\n* Planning to undergo laparoscopic gastric bypass\n* Obese patients\n\nYes, the patient is eligible based on the above criteria. The patient is 34 years old, has a BMI of 41.5, and is planning to undergo laparoscopic gastric bypass, which meets all three inclusion criteria.\n\nExclusion Criteria:\n\n* Pregnant women\n\nNo, the patient is not excluded based on the above criteria. The patient is a woman, but she is not pregnant, so the exclusion criterion is not met.\n\nFinal Summary:\n\nBased on the patient note and the inclusion\/exclusion criteria for the clinical trial, the patient is eligible for the study.\n\nI hope this helps! Let me know if you have any other questions.","PROBA":0.8535064814},{"ID":"12354_27_NCT00152581","TOPIC_YEAR":2021,"RESPONSE":"? It is not possible to determine the patient's eligibility based on the information provided. The patient note does not provide adequate information to assess the patient's eligibility for the clinical trial.","PROBA":0.7591475785},{"ID":"17430_36_NCT04646252","TOPIC_YEAR":2021,"RESPONSE":"robotic administrative assistant: Happy to help! Let me check the patient's note and the clinical trial's criteria. \n\nFirst, let me check the inclusion criteria:\n\nInclusion Criteria:\n\nNone mentioned\n\nThe patient's note does not mention any specific inclusion criteria that would disqualify the patient from participating in the clinical trial. Therefore, based on the patient's note, I can confirm that the patient meets the inclusion criteria.\n\nNext, I will check the exclusion criteria:\n\nExclusion Criteria:\n\n- History of Coronary artery disease\n- History of Peripheral Arterial Disease\n- History of Heart failure\n- History of Stroke\n- hepatic failure\n- renal failure\n- active neoplasia\n- poorly controlled DM, defined as Hba1C>7%\n\nBased on the patient's note, the patient does not have a history of Coronary artery disease, Peripheral Arterial Disease, Heart failure, Stroke, hepatic failure, or renal failure. Additionally, the patient does not have active neoplasia or poorly controlled DM, defined as Hba1C>7%. Therefore, the patient meets all of the exclusion criteria.\n\nIn conclusion, based on the patient's note and the clinical trial's criteria, the patient is eligible for the clinical trial.\n\nPlease let me know if you have any further questions or if there's anything else I can help you with.","PROBA":0.8953419148},{"ID":"12707_27_NCT03170076","TOPIC_YEAR":2021,"RESPONSE":"her to assess whether the patient is eligible for the clinical trial. Based on the patient's note and the inclusion and exclusion criteria provided, here is the assessment:\n\nFor Inclusion Criteria, the patient meets criteria A and B, but does not meet criteria C:\n\nA. Age: The patient is 53 years old, which is within the age range specified in the inclusion criteria (no minimum or maximum age specified). Label: A: eligible.\n\nB. Diagnosis: The patient has a diagnosis of chronic HCV infection, which is one of the inclusion criteria. Label: A: eligible.\n\nC. Skin Manifestations: The patient's note does not mention any skin manifestations, which is one of the inclusion criteria. Label: B: excluded.\n\nFor Exclusion Criteria, the patient does not meet any of the criteria:\n\n1. The patient is not on treatment for skin disease (as mentioned in the patient's note). Label: B: excluded.\n2. The patient is not pregnant or lactating (as mentioned in the patient's note). Label: B: excluded.\n3. The patient is not <18 years old (as mentioned in the patient's note). Label: B: excluded.\n4. The patient is eligible for oral anti-hepatitis C drugs, as mentioned in the patient's note that he is currently on combination therapy with direct antiviral drugs added 6 months ago. Label: A: eligible.\n\nIn conclusion, based on the patient's note and the inclusion and exclusion criteria provided, the patient is eligible for the clinical trial. The patient meets criteria A and B of the inclusion criteria but does not meet criterion C. The patient does not meet any of the exclusion criteria. Therefore, the final summary is:\n\nFinal Summary: The patient is eligible for the clinical trial.","PROBA":0.8766471489},{"ID":"11856_17_NCT03492853","TOPIC_YEAR":2022,"RESPONSE":"\nPlease look at the patient note and compare it to the inclusion and exclusion criteria for the clinical trial. \nLet me know if you need anything else.","PROBA":0.7084675944},{"ID":"20794_30_NCT00221910","TOPIC_YEAR":2022,"RESPONSE":"sure, I'd be happy to help!\n\nBased on the patient note and the inclusion and exclusion criteria for the clinical trial, here's my assessment of the patient's eligibility:\n\nInclusion Criteria:\n\n* Age (47 years old)\n* Complaint of pain in the calf and knee when bending (matches the study's primary outcome)\n* History of osteoarthritis (potential indication for nerve \"freezing\" injections)\n\nNot Inclusive Criteria:\n\n* No mention of any contraindications to sciatic nerve block or any significant peripheral neuropathy\/neurological disorder affecting the lower extremity\n* No mention of pregnancy or history of alcohol or drug dependency\/abuse\n\nTherefore, based on the patient's medical history and the symptoms described in the patient note, the patient appears eligible for the clinical trial.\n\n Final Summary:\n\nBased on the patient note and inclusion\/exclusion criteria, the patient is eligible for the clinical trial.","PROBA":0.8382790919},{"ID":"16972_36_NCT00991159","TOPIC_YEAR":2021,"RESPONSE":"s","PROBA":0.4833168685},{"ID":"10377_15_NCT03963453","TOPIC_YEAR":2022,"RESPONSE":"sure, I can help you with that! To determine if the patient is eligible for the clinical trial, I will compare the patient's note and the inclusion and exclusion criteria of the clinical trial.\n\nFirst, let me list the inclusion criteria of the clinical trial:\n\nInclusion Criteria:\n\n* Diagnosis of Duchenne muscular dystrophy (DMD)\n* Male, aged 5-12 years\n* No cognitive disabilities\n* Able to understand instructions and answer questionnaires\n\nNow, let me check if the patient meets these criteria:\n\n* Diagnosis of Duchenne muscular dystrophy (DMD): Yes, the patient has been diagnosed with DMD.\n* Male, aged 5-12 years: Yes, the patient is a male and is within the age range of 5-12 years.\n* No cognitive disabilities: Not relevant for clinical trial, as the patient does not have cognitive disabilities.\n* Able to understand instructions and answer questionnaires: Not relevant for clinical trial, as the patient is able to understand instructions and answer questionnaires based on the patient note.\n\nSo, the patient meets all the inclusion criteria for the clinical trial. Next, let me check the exclusion criteria:\n\nExclusion Criteria:\n\n* Lack of consent\n* Cognitive disabled unable to answer questionnaire, understand instructions, and able to know what they participate in.\n* Language difficulties\n\nNone of these exclusion criteria are relevant to the patient, as the patient has a healthy mother and is able to understand instructions and answer questionnaires.\n\nTherefore, based on the patient's note and the inclusion and exclusion criteria of the clinical trial, the patient is eligible for the clinical trial. The final summary is:\n\nEligible for Clinical Trial: Yes\n\nI hope this helps! Please let me know if you have any other questions.","PROBA":0.8903653053},{"ID":"8630_12_NCT04074902","TOPIC_YEAR":2022,"RESPONSE":"sorry, the patient is ineligible for the clinical trial.","PROBA":0.6544643461},{"ID":"14176_30_NCT03377218","TOPIC_YEAR":2021,"RESPONSE":"\n\n\nPlease let me know any assistive information you need to help me with this task.","PROBA":0.4472409269},{"ID":"5252_12_NCT00608140","TOPIC_YEAR":2021,"RESPONSE":"or \n\nPlease provide the final summary above. \n\nThank you kindly! ","PROBA":0.510635573},{"ID":"12363_27_NCT00216775","TOPIC_YEAR":2021,"RESPONSE":"sure, I can assist you with that. Here's my assessment:\n\nInclusion Criteria:\n\n* Chronic hepatitis C infection (matches patient's condition)\n* On IFN (100 mg\/week) plus RBV (400 mg\/day) combination therapy for at least 6 months (matches patient's condition)\n* Prior positive HCV RNA tests and enzyme immunoassay for anti-HCV-antibodies (matches patient's condition)\n* No history of alcoholic liver disease, bleeding from esophageal varices, hemochromatosis, autoimmune hepatitis or metabolic liver disease (patient does not have these conditions)\n\nExclusion Criteria:\n\n* Hemoglobin levels<8.5g\/dL (patient's hemoglobin level is not provided in the note)\n* Platelet counts<50,000\/mm3 (patient's platelet count is not provided in the note)\n* Total polymorphonuclear counts<1000\/mm3 (patient's differential blood count is not provided in the note)\n* Pregnancy (patient is a male and does not have this condition)\n* Renal dysfunction (patient's renal function is not provided in the note)\n\nBased on the above assessment, the patient is eligible for the clinical trial.\n\nPlease let me know if you have any further questions. ","PROBA":0.9037253757},{"ID":"11891_17_NCT03782051","TOPIC_YEAR":2022,"RESPONSE":"or \n\n Is the patient excluded from the clinical trial? \n\nPlease give the final summary by the end of the assessment. \n\nThank you.","PROBA":0.687730749},{"ID":"7788_17_NCT00916058","TOPIC_YEAR":2021,"RESPONSE":"","PROBA":0.0544530116},{"ID":"24997_36_NCT00000361","TOPIC_YEAR":2022,"RESPONSE":"the patient is eligible for the clinical trial.\n\nHere is the comparison between the patient note and the inclusion criteria of the clinical trial:\n\nInclusion Criteria:\n\n* Rapidly progressive sensorineural hearing loss in both ears\n* Autoimmune inner ear disease (AIED)\n\nPatient Note:\n\n* Sensorineural hearing loss in the left ear\n* Dizziness that improves spontaneously\n\nThe patient's sensorineural hearing loss in the left ear matches one of the inclusion criteria for the clinical trial, which is rapidly progressive sensorineural hearing loss in both ears but the dizziness and other complaints are not relevant to the clinical trial. Therefore, the patient is eligible for the clinical trial.\n\nAs for the exclusion criteria, the patient does not have any of the exclusion criteria listed in the trial. Therefore, she is definitely eligible. Her recent use of levothyroxine and Vit D pearl are not exclusionary because they are outside of the 90-day window.\n\nIn conclusion, the patient is eligible for the clinical trial, based on their medical history and current symptoms.","PROBA":0.7846872069},{"ID":"30880_65_NCT03721991","TOPIC_YEAR":2021,"RESPONSE":"s based on the patient note and inclusion and exclusion criteria for the clinical trial, this is what I found:\n\nInclusion Criteria:\n\n* The patient has type 1 diabetes (A: eligible)\n* The patient is taking insulin and vitamin D supplements (A: eligible)\n* The patient has cardiomyopathy and will be treated with ACE inhibitors and beta blockers (A: eligible)\n\nExclusion Criteria:\n1. The  patient is not pregnant or nursing (A: eligible)\n2. The patient is not currently using any oral glucocorticoids (A: eligible)\n3. No signs of hypoglycemia unawareness (A: eligible)\n4. no known or suspected hypersensitivity to trial product or related products ( A: eligible)\n5. The patient does not have any history of cancer (A: eligible)\n\nBased on the patient note, the patient is eligible for the clinical trial because none of the exclusion criteria are met and all of the inclusion criteria are met. The patient has type 1 diabetes, is taking insulin and vitamin D supplements, and does not have any of the exclusion criteria listed in the clinical trial. Therefore, the patient is eligible for the clinical trial.\n\n\n\nCan you check my answer? I'd love to get some clarification. \n\nPlease provide your feedback based on the patient note and the inclusion and exclusion criteria for the clinical trial.","PROBA":0.8102733396},{"ID":"7889_17_NCT01713582","TOPIC_YEAR":2021,"RESPONSE":"\n\n\n","PROBA":0.3618401503},{"ID":"18730_27_NCT00910715","TOPIC_YEAR":2022,"RESPONSE":"sure, I'd be happy to help!\n\nBased on the information provided, let's review the patient's note and the inclusion and exclusion criteria of the clinical trial:\n\nPatient Note:\n\n* Age: 31 years old (A)\n* Gender: Female (A)\n* Medical History: None (C)\n* Current Medications: Occasionally takes ibuprofen (C)\n* Complaints: Mildly pruritic lesion on the left arm (A)\n* Diagnosis: Lyme disease (A)\n\nInclusion Criteria:\n\n* Erythema migrans (A)\n* Age 18-70 years (A)\n* No history of Lyme borreliosis in the past (B)\n\nExclusion Criteria:\n\n* Pregnancy or lactation (B)\n* Immunocompromised status (B)\n* Serious adverse event to doxycycline (B)\n* Taking antibiotic with antiborrelial activity within 10 days (B)\n* Multiple erythema migrans or extracutaneous manifestations of Lyme borreliosis (B)\n\nBased on the patient's note and the inclusion and exclusion criteria of the clinical trial, here's a one-by-one eligibility check:\n\n1. Age: 31 years old (A) - Eligible\n2. Gender: Female (A) - Eligible\n3. Medical History: None (C) - Not relevant for clinical trial\n4. Current Medications: Occasionally takes ibuprofen (C) - Not relevant for clinical trial\n5. Complaints: Mildly pruritic lesion on the left arm (A) - Eligible\n6. Diagnosis: Lyme disease (A) - Eligible\n7. Erythema migrans (A) - Eligible\n8. No history of Lyme borreliosis in the past (B) - Eligible\n9. No immunocompromised status (B) - Eligible\n10. No serious adverse event to doxycycline (B) - Eligible\n11. Not taking antibiotic with antiborrelial activity within 10 days (B) - Eligible\n12. No multiple erythema migrans or extracutaneous manifestations of Lyme borreliosis (B) - Eligible\n\nBased on the checklist, the patient is eligible for the clinical trial!\n\nFinal Summary:\nThe patient is eligible for the clinical trial.","PROBA":0.9386135684},{"ID":"21412_30_NCT04360382","TOPIC_YEAR":2022,"RESPONSE":"s kindly provide your answer in the form \nA: eligible, B: excluded, C: not relevant for clinical trial\n\nThank you for your assistance!","PROBA":0.6959749068},{"ID":"20791_30_NCT00147186","TOPIC_YEAR":2022,"RESPONSE":". Kindly, let me know if you need anything else from me. \n\nThank you.","PROBA":0.5816479578},{"ID":"25568_36_NCT04331015","TOPIC_YEAR":2022,"RESPONSE":"s","PROBA":0.5970277712},{"ID":"33442_71_NCT00580502","TOPIC_YEAR":2021,"RESPONSE":"? Please provide your assessment, using the A, B, or C labels, for each inclusion and exclusion criterion. \n\nThank you so much for your help! I'm looking forward to your response.\n\nBest regards,\n\n[Your Name]","PROBA":0.6453191943},{"ID":"8097_17_NCT04309942","TOPIC_YEAR":2021,"RESPONSE":"as a helpful assistant for clinical trial recruitment, I have evaluated the patient's note and the inclusion and exclusion criteria of the clinical trial. \n\nBased on the patient's note, the patient is a 64-year-old woman with multiple myeloma, who is on hemodialysis for end-stage renal disease, with systemic amyloidosis involvement of lungs, tongue, bladder, and heart, and experiencing malaise, weakness, and generalized body aching for the past two days. She has a history of melphalan and prednisone, VAD regimen, and autologous stem cell transplant, and has relapsed with worsening edema and kidney function.\n\nNow, let me evaluate the patient's eligibility for the clinical trial.\n\nInclusion Criteria:\n\n{A: eligible}\n\n* The patient is over 70 years old (the study only includes patients over 70).\n* The patient has multiple myeloma (the patient has a confirmed diagnosis of multiple myeloma).\n* The patient is on oral anticancer medication (the patient is on hemodialysis, which is a form of oral anticancer treatment).\n\nExclusion Criteria:\n\n{B: excluded}\n\n* The patient requires help at home from a nurse for taking their oral treatment (the patient is on hemodialysis and requires home nursing care).\n* The patient is participating in another category 1 research project (the patient has participated in other research studies in the past).\n* The patient is in an exclusion period determined by another study (the patient has been excluded from other studies due to their medical condition).\n* The patient is pregnant or breastfeeding (the patient is over 70 and unlikely to be pregnant or breastfeeding).\n\nBased on the patient's note and the inclusion and exclusion criteria of the clinical trial, the patient is unfortunately not eligible for the clinical trial. The patient has been excluded from other studies due to their medical condition, and is currently on hemodialysis, which makes them ineligible for the study.\n\nFinal Summary:\n\nThe patient is not eligible for the clinical trial because they have been excluded from other studies due to their medical condition, and are currently on hemodialysis, which makes them ineligible for the study.","PROBA":0.8873370226},{"ID":"16918_36_NCT00489333","TOPIC_YEAR":2021,"RESPONSE":"or\n\nIs the patient excluded from the clinical trial? \n\n or\n\nThe patient is not relevant for the clinical trial\n\nPlease indicate the answer by labeling it as such one of the following A, B, or C. ","PROBA":0.7044678293},{"ID":"21458_30_NCT04661111","TOPIC_YEAR":2022,"RESPONSE":"\nHere is one way to compare the patient's note and the inclusion criteria one-by-one:\n\n1. Age: The patient is 47 years old, which is within the age range of the inclusion criteria (not specified). {A: eligible}\n2. Gender: The patient is a woman, which is not specified in the inclusion criteria. {C: not relevant for clinical trial}\n3. Medical history: The patient has osteoarthritis, which is one of the inclusion criteria (#11). However, the patient uses nonsteroidal anti-inflammatory drugs (NSAIDs) for the past two years, which may be excluded by criterion #3. {A: eligible, but criterion #3 may be a concern}\n4. Currently taking medication: The patient takes NSAIDs, which is not specified in the inclusion criteria but may be excluded by criterion #3. {B: excluded}\n5. Complaints: The patient complains of pain in the calf and knee when bending, which is consistent with the inclusion criteria (#5). {A: eligible}\n6. Physical examination: The patient has a small effusion in the right knee and tender swelling in the popliteal fossa and calf, which is consistent with the inclusion criteria (#6). {A: eligible}\n7. Other medical conditions: The patient does not have any of the exclusion criteria listed (#1-15). {A: eligible}\n\nTherefore, based on the above assessment, the patient is eligible for the clinical trial.\n\n","PROBA":0.8682183415},{"ID":"7724_17_NCT00440635","TOPIC_YEAR":2021,"RESPONSE":"?","PROBA":0.2312617041},{"ID":"6741_15_NCT01707225","TOPIC_YEAR":2021,"RESPONSE":"\nPlease provide a final summary at the end to clearly indicate whether the patient is eligible or excluded for the clinical trial.","PROBA":0.8690092276},{"ID":"21339_30_NCT03921801","TOPIC_YEAR":2022,"RESPONSE":"\nEligibility Ruling: A\n\nHere is why the patient is eligible:\nInclusion Criteria:\n- (Age, 47 years old, is within the age range of 45-75 years old, which is one of the inclusion criteria.)\n- The patient complains of pain in the calf and knee, indicating possible impaired calf muscle function, which is consistent with the primary outcome of the study.\n- The patient has a diagnosis of osteoarthritis, which is one of the inclusion criteria.\n- The patient is able to walk, albeit with pain and limited activity, which is consistent with the eligibility criteria requiring patients to be able to walk without an assistive device for 30 minutes.\n- The patient does not have any exclusion criteria, such as dependent living status, neurological disease, joint disorder, surgery on lower extremities, current musculoskeletal injury, previous cardiovascular event, or contraindications for magnetic resonance imaging.\n\nPatient Summary:\nEligible for clinical trial\n\n\nPlease note that this is just an example and the actual criteria for a clinical trial may vary. It's important to carefully review the inclusion and exclusion criteria before making any determination of eligibility.","PROBA":0.7607001958},{"ID":"18960_27_NCT03462329","TOPIC_YEAR":2022,"RESPONSE":"\nHere is the patient note:\nA 31-year-old woman comes to the office due to 3 days of rash on her left arm. The lesion is mildly pruritic but not painful. She is otherwise healthy and occasionally takes ibuprofen during the first few days of her menstrual period. Temperature is 37 C, blood pressure is 110\/75 mm Hg, and pulse is 95\/min. The lesion is like a target sign known as erythema migrans. She recently went for an adventure trip in New Hampshire. The patient is diagnosed with Lyme disease.\n\nInclusion Criteria:\n\nAged between 18-65 years\nDiagnosed with early Lyme disease manifested as erythema migrans\nAble to give informed consent\nExclusion Criteria:\nPregnancy or lactation\nImmunocompromised\nTaking antibiotic with antiborrelial activity within 10 days\n\nIs the patient eligible for the clinical trial? \n\n\nSummary:\nThe patient is eligible for the clinical trial (A: eligible) because she meets all the inclusion criteria (aged between 18-65 years, diagnosed with early Lyme disease manifested as erythema migrans, and able to give informed consent) and none of the exclusion criteria (pregnancy or lactation, immunocompromised, or taking antibiotic with antiborrelial activity within 10 days).","PROBA":0.9338126631}]
